Home » Newsletters » BioWorld Science

BioWorld Science

May 6, 1998

View Archived Issues

C-C chemokines implicated in the pathogenesis of CHF

Company Profile: Gemma Biotechnology

Novo Nordisk: Annual Report 1997

New antitumor compounds from Ajinomoto

Sanguine funds development of blood substitute

Noven and Novartis establish joint venture to promote Vivelle

FDA approves SuperGen's injectable mitomycin

GenVec, Fuso collaborate on cancer gene therapies

Profile of a factor Xa inhibitor in development at Yamanouchi

Patient enrollment complete for phase III trial of GL-701 in SLE

Hemolink cleared by FDA for phase II testing in chronic anemia

Signal awarded SBIR phase II grant for osteoporosis research

SSRIs safe and effective for elderly depressed patients with heart disease

Naked DNA vaccine shows promise against malaria

Bisaramil compared to lidocaine for effects on Na+ channels

Results of Neutralase phase II trial presented

Sagami presents new anti-H. pylori agents

Apoptosis-inducing iminodiacetic acid derivatives described by Mitsui Toatsu

BE-56980: new antitumor agent discovered by Banyu

Research at Kyorin leads to effective blood glucose-lowering agents

Pharmacological profile of Otsuka's OPB-2045

WF-10 to enter U.S. trials for follicular lymphoma

Spotlight on P2Y2 agonists: a new target for cystic fibrosis

FDA advisory committee recommends approval of drug combination for hepatitis C

Results from clinical trial of Altropane for the diagnosis of PD

Fuisz and Pfizer enter drug delivery collaboration

SB-240563, an anti-IL-5 MAb for the treatment of asthma

Scios submits NDA for Natrecor

CytoMed's 5-LO inhibitor shows potential in asthma; clinical trials imminent

Advisory committee recommends FDA approval for TB treatment

FDA approves test to identify risk of preterm labor

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...